Azaserine inhibits the rate limiting step of the metabolic hexosamine pathway and irreversibly inhibits γ-glutamyltransferase by acting directly at the substrate-binding pocket.
Azaserine interferes with the rate-limiting phase of the metabolic hexosamine pathway and permanently stops γ-glutamyltransferase function by directly affecting the substrate-binding pocket.